RxDoctor Payments Data

Meghan McCullough, MD

Hand Surgery · Los Angeles, CANPI 1265835383

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,424 of the $7,239 with a category attached, or 61.1%. It is spread thinly across 20 manufacturers, the largest accounting for just 20.9%. Reporting peaked in 2022 at $2,283 and has fallen 96.4% since, to $83 in 2025.

$7,239in general payments, 2019–2025

Across 44 payments — averaging $164.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Musculoskeletal Transplant Foundation Inc.$2K
  • Axogen$1K
  • Evolution Surgical, Inc$1K
  • Polynovo North America LLC$753
  • KCI USA, Inc.$425
  • Acumed LLC$362
  • plus $2K from 14 others
$27,258in research payments, 2019–2025

Across 2 payments — averaging $13,629 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Musculoskeletal Transplant Foundation Inc.$27K

What the payments were for

  • Consulting fees$4256%
  • Travel & lodging$1,18916%
  • Food & beverage$4,42461%
  • Education$1,20017%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,239 in reported general payments places this provider in the 70th percentile of 249 hand surgery providers in California.

See all hand surgery providers in California

Medicare billing

Part B allowed, 2024
$162,867
Medicare patients
293
Services billed
1,449

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen16$83
Methylprednisolone12$74
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim11$35
Meloxicam14$31
Tramadol Hcl11$12

Paid to pharmacies, not to this prescriber.

Other hand surgery in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →